ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,788Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 131

$2.82M Total Retail Price of All Prescriptions

Rank: 1 out of 131

973 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 973 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 29,658 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,776 1,469 1 1
OMEPRAZOLE 1,313 1,060 2 4
AMLODIPINE BESYLATE 1,230 1,050 3 2
JANUVIA 880 698 4 32
CRESTOR 774 638 5 19
LOSARTAN-HYDROCHLOROTHIAZIDE 769 672 6 58
FUROSEMIDE 749 631 7 3
MELOXICAM 686 522 8 39
CARVEDILOL 648 592 9 25
LISINOPRIL 647 459 10 6
METFORMIN HCL 613 478 11 8
TRAMADOL HCL-ACETAMINOPHEN 611 451 12 92
LOVAZA 603 412 13 41
DIOVAN HCT 555 482 14 62
TAMSULOSIN HCL 532 461 15 24
ATORVASTATIN CALCIUM 507 394 16 11
RANITIDINE HCL 499 413 17 35
MECLIZINE HCL 490 430 18 79
CLOPIDOGREL 478 399 19 28
VOLTAREN 440 348 20 59
GABAPENTIN 439 337 21 20
NEXIUM 399 308 22 16
METOPROLOL SUCCINATE 376 299 23 10
GLYBURIDE-METFORMIN HCL 366 278 R 24 80
GLIMEPIRIDE 360 307 25 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 358 295 26 70
TRAMADOL HCL 351 259 27 31
ADVAIR DISKUS 351 268 27 33
DONEPEZIL HCL 350 328 29 17
PLAVIX 342 301 30 36
NAMENDA 339 323 31 26
HYDROCHLOROTHIAZIDE 333 305 32 12
SINGULAIR 325 247 33 56
LEVOTHYROXINE SODIUM 320 252 34 5
TRAZODONE HCL 316 253 35 40
PRAVASTATIN SODIUM 275 232 36 46
EVISTA 269 198 37 119
MICARDIS HCT 268 205 10 38 168
LOSARTAN POTASSIUM 268 225 38 21
AMMONIUM LACTATE 265 206 40 76
DIOVAN 263 224 41 30
JANUMET 260 180 42 121
ALENDRONATE SODIUM 259 235 43 23
FINASTERIDE 256 203 44 77
AMLODIPINE BESYLATE-BENAZEPRIL 242 224 45 66
ZOLPIDEM TARTRATE 241 209 46 15
LANTUS SOLOSTAR 236 151 47 158
CITALOPRAM HBR 234 162 48 22
NAPROXEN 223 141 49 69
EXELON 221 207 50 94
METOPROLOL TARTRATE 216 152 51 7
LANSOPRAZOLE 216 142 51 111
IBUPROFEN 197 154 53 48
SERTRALINE HCL 187 133 54 27
PROAIR HFA 184 122 55 65
PAROXETINE HCL 178 122 56 83
LABETALOL HCL 177 143 57 139
ZETIA 169 110 58 109
SPIRIVA 166 141 59 57
MONTELUKAST SODIUM 160 117 60 114
BENICAR HCT 158 105 61 210
WARFARIN SODIUM 155 142 62 9
BYSTOLIC 145 78 63 118
AVODART 144 128 64 172
EXFORGE 143 129 65 144
ATENOLOL-CHLORTHALIDONE 140 116 66 145
ESCITALOPRAM OXALATE 140 89 66 63
CLOTRIMAZOLE-BETAMETHASONE 139 115 68 61
LACTULOSE 138 108 69 54
VESICARE 133 126 70 163
LIPITOR 133 107 70 98
NIFEDIPINE ER 132 113 72 111
ALCOHOL PREP PADS 129 113 73 228
ISOSORBIDE MONONITRATE ER 127 108 74 45
FLUTICASONE PROPIONATE 125 95 75 78
COREG CR 122 86 76 237
ATENOLOL 119 117 77 14
VENTOLIN HFA 113 83 78 85
IBANDRONATE SODIUM 112 85 79 241
GLYBURIDE 112 102 R 79 55
METFORMIN HCL ER 110 96 81 136
SINGLE USE SWAB 108 77 82 242
ZOSTAVAX 107 98 83 244
FLOVENT HFA 106 69 84 149
NOVOLOG FLEXPEN 102 71 85 179
BISOPROLOL FUMARATE 100 94 86 250
BISOPROLOL-HYDROCHLOROTHIAZIDE 99 99 87 161
ACARBOSE 99 90 87 251
TIZANIDINE HCL 98 90 89 254
LOVASTATIN 98 95 89 67
ENALAPRIL MALEATE 97 70 91 18
FLECTOR 93 84 92 258
LEVEMIR FLEXPEN 92 57 93 137
TEKTURNA 87 86 94 263
EXFORGE HCT 86 84 95 265
ENABLEX 83 74 96 269
CHLORTHALIDONE 80 56 97 225
PANTOPRAZOLE SODIUM 80 77 97 93
VALSARTAN-HYDROCHLOROTHIAZIDE 79 64 99 227
BENAZEPRIL HCL 77 66 100 152
COMBIVENT 76 72 101 194
RANEXA 75 67 102 203
CELEBREX 73 48 103 108
FENOFIBRATE 73 61 103 124
AMITIZA 73 64 103 159
ALCOHOL SWABS 73 41 103 222
CROMOLYN SODIUM 72 58 107 283
FAMOTIDINE 71 45 108 44
SYMBICORT 71 55 108 146
LANTUS 70 57 110 53
DEXILANT 70 68 110 286
LYRICA 68 47 112 103
RAMIPRIL 67 63 113 73
XOPENEX HFA 67 63 113 290
CLOTRIMAZOLE 66 57 115 216
PENNSAID 65 56 116 224
DIGOXIN 65 54 116 49
MEGESTROL ACETATE 64 64 R 118 206
ALFUZOSIN HCL 64 55 118 297
SURE COMFORT ALCOHOL 64 53 118 297
SPIRONOLACTONE 62 61 121 86
PROCTOZONE-HC 62 35 121 190
CLONIDINE HCL 60 19 123 72
TRILIPIX 59 31 124 220
DILTIAZEM 24HR CD 59 59 124 127
MIRTAZAPINE 58 55 126 34
ALLOPURINOL 57 34 127 52
AGGRENOX 53 41 128 212
SEROQUEL XR 53 45 128 323
CIPROFLOXACIN HCL 52 40 130 74
HYDROXYZINE HCL 52 33 R 130 159
BONIVA 51 44 132 329
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.